Matrixx Investment In Novel Oral Care Product Drags Down Q2 Income
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives' second-quarter profits were impacted by higher R&D expenditure on a new oral care product that offers a "very unique delivery system," the firm announced during an earnings call July 25